Rebalix
Amundi · sheet of 20 October 2026
Amundi · sheet of 20 October 2026ETF sheet · official issuer and register data
Amundi Core S&P 500 Swap UCITS ETF Acc
SP5C · LU1135865084 · class UCITS ETF Acc · USD · domicile Luxembourg
Equity · United States · Large capSFDR art. 6
Index tracked: S&P 500 Net Total Return Index
- TER
- 0.05%+ trans. 0.00%
- Fund size
- 17.3 bn EUR
- Tracking difference
- +0.45%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Synthetic (swap)
- Income
- Accumulating
Launch 9 Dec 2014 · costs from the KID as of 2 Oct 2026 · 533 securities held · 12 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 7 Aug 2026
The Fund is an index-tracking UCITS passively managed. The investment objective of MULTI UNITS LUXEMBOURG - Amundi Core S&P 500 Swap (the “Sub-Fund”) is to track both the upward and the downward evolution of the S&P 500® Net Total Return (the "Index") denominated in US Dollars - while minimising the volatility of the difference between the return of the Sub-Fund and the return of the Index (the “Tracking Error”). The Index is a free-float capitalization-weighted index, representative of the performance of the 500 leading U.S. companies listed in the…
Performance since series start (in euro) — base 100
9 Dec 2014 → 16 Oct 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +19.9% |
| 3 years | +70.2% |
| 5 years | +88.7% |
| 10 years | +309.5% |
| Since series start | +395.7% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 13.17% | 15.57% | 17.54% |
| Max drawdown | −9.11% | −18.55% | −25.21% |
| Sharpe | 1.11 | 1.18 | 0.64 |
| Sortino | 1.62 | 1.75 | 0.91 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · SP5C · LU11358650841
RebalixSP5C · LU1135865084 · sheet of 20 October 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +17.41% | +17.43% | −0.02% |
| 2024 | +25.26% | +24.50% | +0.76% |
| 2023 | +26.27% | +25.67% | +0.60% |
| 2022 | −17.93% | −18.51% | +0.58% |
| 2021 | +27.67% | +28.16% | −0.49% |
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 30 Sept 2026 · 533 securities · top-10 weight = 42.6%
| Top holdings | Weight |
|---|---|
| 8.8% | |
| 7.4% | |
| 6.7% | |
| 5.8% | |
| 3.1% | |
| 2.7% | |
| 2.7% | |
| 1.9% | |
| 1.9% | |
| 1.7% |
Listing venues
ESMA register (FIRDS) and official exchange lists
SP5C · Borsa Italiana (ETFplus), Euronext Paris, SIX Swiss Exchange
LYP5 · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
— · London Stock Exchange
+ 8 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/LU1135865084
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/LU1135865084
Series, distributions, holdings and documents refresh daily.
Sheet produced on 20 October 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · SP5C · LU11358650842